June 1-5, 2018

International Scientific Programme Committee

Committee Co-chairs

Dr. Tammy Clifford, CADTH, Canada

Dr. Tammy Clifford, CADTH, Canada

Dr. Tammy Clifford is CADTH’s Chief Scientist and Vice-President, Evidence Standards.  Over the past dozen years, she has served in a number of senior leadership roles at CADTH, with responsibility for the agency’s Health Technology Assessment (HTA), Horizon Scanning, Rapid Response, Scientific Advice and Patient Engagement programs. Tammy received her PhD in Epidemiology & Biostatistics at the University of Western Ontario, and her BSc and MSc from McGill. Through her role as an adjunct professor with the School of Epidemiology, Public Health & Preventive Medicine at the University of Ottawa, Tammy is building awareness of and capacity in HTA through her active involvement with the graduate program. She has been actively involved with national and international HTA activities, including having served on the Board of Directors of Health Technology Assessment international (HTAi), and having participated in the development of the scientific programmes for many HTAi annual meetings. Tammy is also an Associate Editor with IJTAHC.  She is internationally recognized for her passion and commitment to advancing the science of HTA, and to mentoring the next generation of HTA producers.

 

SaveSave

SaveSave

SaveSaveSaveSave

SaveSave

SaveSave

Dr. Alric Rüther, IQWiG, Germany

Dr. Alric Rüther, IQWiG, Germany

Alric Rüther is a physician trained in Internal Medicine and Oncology. Based on his engagement in Evidence Based Medicine and Cochrane Collaboration, he worked to establish and build the discipline of Health Technology Assessment in Germany. Alric is founder of the German Agency for HTA (DAHTA) at DIMDI, Federal Ministry of Health. In 2007, Alric moved to the Institute of Quality and Efficiency in Health Care (IQWiG), heading the Department of Health Care Quality. His main task of the department was to identify and describe Health Care Standards based on Clinical Practice Guidelines, i.e. as scientific background for Disease Management Programs (DMP). Additionally, Alric was responsible for the development and maintenance of the international relationships of IQWiG. This led to the establishment of the Department of International Affairs at IQWiG in 2015, which Alric is leading now. Alric has been engaged in worldwide HTA development for more than 10 years: with the HTAi since its founding (Board member since 2013; Chair of Annual Meeting Committee from 2016 to 2017; Chair of Scientific Development and Capacity Building Advisory Committee since 2017); INAHTA (Vice Chair until 2006; Chair of internal communications from 2005 to 2016); EUnetHTA (founding member; Chair of plenary from 2010 to 2012; Lead Partner Quality Management, Scientific Guidance and Tools [WP6] Joint Action 3 from 2016); and ISPOR (Chair of HTA roundtable Europe from 2013 to 2016). Alric is also an associate professor at the Universities of Bielefeld and Berlin, lecturing HTA.

 

SaveSave

SaveSaveSaveSave

SaveSave

SaveSave

Committee Members

Dr. Nick Bansback
University of British Columbia, Canada

Mr. Ken Bond
CADTH, Canada

Ms. Mirella Marlow
NICE, UK

Dr. Oriana Ciani
University of Exeter, UK

Dr. Fiona Clement
University of Calgary, Canada

Ms. Sophie Cros
Abbott, Belgium

Dr. Paul Fennessy
Dept. of Health & Human Services, Australia

 

 

 

Dr. Rabia Kahveci
ANHTA, Turkey

Dr. Sebastian Garcia Marti
IECS, Argentina

Dr. Newell McElwee
Boehringer-Ingleheim, USA

Ms. Debjani Mueller
WHO, South Africa

Dr. Daniel Ollendorf
ICER, USA

Dr. Keng Ho Pwee
Eastern Health, Singapore

 

Dr. Máirín Ryan
HIQA, Ireland

Dr. Bettina Ryll
Melanoma Patient Network Europe, Sweden

Dr. Dima Samaha
LA-SER Analytica, UK

Dr. Sangjin Shin
NECA, South Korea

Dr. Sean Sullivan
University of Washington, USA

Dr. Sophie Werkö
SBU, Sweden